参考文献/References:
[1]陈溥言. 兽医传染病学[M]. 北京:中国农业出版社, 2006.
[2]殷震. 动物病毒学[M]. 北京:科学出版社, 1997.
[3]CARGNELUTTI J F, MASUDA E K, MARTINS M, et al. Virological and clinico-pathological Features of ORF virus inFection in experimentally inFected rabbits and mice[J]. Microbial Pathogenesis, 2011, 50(1):56-62.
[4]涂明亮,安维雪,张志丹,等. 羊口疮病毒内蒙株的生物学特性[J]. 中国兽医学报, 2016, 36(8):1349-1353.
[5]王盈盈,贾怀杰,白刚,等. 羊口疮病毒甘肃流行株的分离鉴定及其ORF070基因和ORF109基因的序列分析[J]. 中国兽医科学, 2013(8):782-787.
[6]王晴楠,张凯照,宁章勇. 我国 1984-2014 年羊口疮报道文献的统计分析[J].畜牧与兽医, 2015, 47(9): 111-113.
[7]ZHANG K, LIU Y, KONG H, et al. Comparison and phylogenetic analysis based on the B2L gene[J]. Arch Virol, 2014,159(6):1475-1479.
[8]CZERNY C P, WALDMANN R, SCHEUBECK T. Identification of three distinct antigenic sites in parapoxviruses[J]. Archives of Virology, 1997, 142(4): 807-821.
[9]KARCH C P, BURKHARD P. Vaccine technologies: from whole organisms to rationally designed protein assemblies[J]. Biochem Pharmacol, 2016,120:1-14.
[10]DELHON G, TULMAN E R, AFONSO C L, et al. Genomes of the parapoxviruses ORF virus and bovine papular stomatitis virus[J]. Journal of Virology, 2003, 78(1): 168-177.
[11]SCAGLIARINI A, CIULLI S, BATTILANI M, et al. Characterisation of immunodominant protein encoded by the F1L gene of ORF virus strains isolated in Italy[J]. Archives of Virology, 2002, 147(10): 1989-1995.
[12]CZERNY C P, Waldmann R, Scheubeck T. Identification of three distinct antigenic sites in parapoxviruses[J]. Archives of Virology, 1997, 142(4): 807-821.
[13]KANEKIYO M, WEI C J, YASSINE H M, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies[J]. Nature ,2013, 499:102-106.
[14]KANEKIYO M, BU W, JOYCE M G, et al. Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site[J].Cell, 2015, 162:1090-1100.
[15]LI C Q, SOISTMAN E, CARTER D C. Ferritin nanoparticle technology. A new platform for antigen presentation and vaccine development [J]. Ind Biotechnol, 2006,2(2):143-147.
[16]ZHAO H, YAO X, XUE C, et al. Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha2b fusion protein by linker engineering[J]. Protein Expr Purif, 2008,61:73-77.
[17]BAI Y, SHEN W C. Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization[J]. Pharm Res, 2006,23:2116-2121.
[18]CHEN X, ZARO J L, SHEN W C. Fusion protein linkers: property, design and functionality[J]. Adv Drug Deliv Rev, 2013,65(10):1357-1369.
[19]PALERMO L M, HAFENSTEIN S L, Parrish C R. Purified feline and canine transferrin receptors reveal complex interactions with the capsids of canine and feline parvoviruses that correspond to their host ranges[J]. Journal of Virology, 2006, 80(17):8482-8492.